These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 28116572)

  • 1. UCH-L1 Expressed by Podocytes: a Potentially Therapeutic Target for Lupus Nephritis?
    Cui JH; Xie X
    Inflammation; 2017 Apr; 40(2):657-665. PubMed ID: 28116572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NF-κB upregulates ubiquitin C-terminal hydrolase 1 in diseased podocytes in glomerulonephritis.
    Zhang H; Mao X; Sun Y; Hu R; Luo W; Zhao Z; Chen Q; Zhang Z
    Mol Med Rep; 2015 Aug; 12(2):2893-901. PubMed ID: 25976522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The regulation of the UCH-L1 gene by transcription factor NF-κB in podocytes.
    Zhang H; Sun Y; Hu R; Luo W; Mao X; Zhao Z; Chen Q; Zhang Z
    Cell Signal; 2013 Jul; 25(7):1574-85. PubMed ID: 23567262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of A20/TNFAIP3 deficiency in lupus nephritis in MRL/lpr mice.
    Sun L; Zou LX; Han YC; Zhu DD; Chen T; Wang J
    Clin Exp Nephrol; 2020 Feb; 24(2):107-118. PubMed ID: 31811410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new role for the neuronal ubiquitin C-terminal hydrolase-L1 (UCH-L1) in podocyte process formation and podocyte injury in human glomerulopathies.
    Meyer-Schwesinger C; Meyer TN; Münster S; Klug P; Saleem M; Helmchen U; Stahl RA
    J Pathol; 2009 Feb; 217(3):452-64. PubMed ID: 18985619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UCH-L1 induces podocyte hypertrophy in membranous nephropathy by protein accumulation.
    Lohmann F; Sachs M; Meyer TN; Sievert H; Lindenmeyer MT; Wiech T; Cohen CD; Balabanov S; Stahl RA; Meyer-Schwesinger C
    Biochim Biophys Acta; 2014 Jul; 1842(7):945-58. PubMed ID: 24583340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UCH-L1 expression of podocytes in diseased glomeruli and in vitro.
    Liu Y; Wu J; Wu H; Wang T; Gan H; Zhang X; Liu Y; Li R; Zhao Z; Chen Q; Guo M; Zhang Z
    J Pathol; 2009 Apr; 217(5):642-53. PubMed ID: 19214988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ubiquitin C-Terminal Hydrolase L1 is required for regulated protein degradation through the ubiquitin proteasome system in kidney.
    Radón V; Czesla M; Reichelt J; Fehlert J; Hammel A; Rosendahl A; Knop JH; Wiech T; Wenzel UO; Sachs M; Reinicke AT; Stahl RAK; Meyer-Schwesinger C
    Kidney Int; 2018 Jan; 93(1):110-127. PubMed ID: 28754552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wnt/β-Catenin Signaling Mediated-UCH-L1 Expression in Podocytes of Diabetic Nephropathy.
    Zhang H; Luo W; Sun Y; Qiao Y; Zhang L; Zhao Z; Lv S
    Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27571062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A20 overexpression exerts protective effects on podocyte injury in lupus nephritis by downregulating UCH-L1.
    Sun L; Zou LX; Han YC; Wu L; Chen T; Zhu DD; Hu P
    J Cell Physiol; 2019 Sep; 234(9):16191-16204. PubMed ID: 30805933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ubiquitin C-terminal hydrolase-l1 activity induces polyubiquitin accumulation in podocytes and increases proteinuria in rat membranous nephropathy.
    Meyer-Schwesinger C; Meyer TN; Sievert H; Hoxha E; Sachs M; Klupp EM; Münster S; Balabanov S; Carrier L; Helmchen U; Thaiss F; Stahl RA
    Am J Pathol; 2011 May; 178(5):2044-57. PubMed ID: 21514420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-functional ubiquitin C-terminal hydrolase L1 drives podocyte injury through impairing proteasomes in autoimmune glomerulonephritis.
    Reichelt J; Sachs W; Frömbling S; Fehlert J; Studencka-Turski M; Betz A; Loreth D; Blume L; Witt S; Pohl S; Brand J; Czesla M; Knop J; Florea BI; Zielinski S; Sachs M; Hoxha E; Hermans-Borgmeyer I; Zahner G; Wiech T; Krüger E; Meyer-Schwesinger C
    Nat Commun; 2023 Apr; 14(1):2114. PubMed ID: 37055432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Podocytes and autophagy: a potential therapeutic target in lupus nephritis.
    Zhou XJ; Klionsky DJ; Zhang H
    Autophagy; 2019 May; 15(5):908-912. PubMed ID: 30755075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of UCH-L1 expression by pre-embedding immunoelectron microscopy with colloidal gold labeling in diseased glomeruli.
    Liu Y; Wu H; Wu J; Wang S; Liu Y; Zhao Z; Zhang X; Li R; Guo M; Zhang Z
    Ultrastruct Pathol; 2008; 32(1):5-9. PubMed ID: 18300032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plakoglobin is involved in cytoskeletal rearrangement of podocytes under the regulation of UCH-L1.
    Fang Y; Li F; Qi C; Mao X; Xu Y; Zhao Z; Wu H; Zhang Z
    Biochem Biophys Res Commun; 2020 Aug; 529(1):112-118. PubMed ID: 32560811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of Toll-like receptor 9 in renal podocytes in childhood-onset active and inactive lupus nephritis.
    Machida H; Ito S; Hirose T; Takeshita F; Oshiro H; Nakamura T; Mori M; Inayama Y; Yan K; Kobayashi N; Yokota S
    Nephrol Dial Transplant; 2010 Aug; 25(8):2530-537. PubMed ID: 20181802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulated expression of cardiac ankyrin-repeated protein in renal podocytes is associated with proteinuria severity in lupus nephritis.
    Matsuura K; Uesugi N; Hijiya N; Uchida T; Moriyama M
    Hum Pathol; 2007 Mar; 38(3):410-9. PubMed ID: 17239933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The functions of UCH-L1 and its relation to neurodegenerative diseases.
    Setsuie R; Wada K
    Neurochem Int; 2007; 51(2-4):105-11. PubMed ID: 17586089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune podocytes in the immune microenvironment of lupus nephritis (Review).
    Liu R; Wen X; Peng X; Zhao M; Mi L; Lei J; Xu K
    Mol Med Rep; 2023 Nov; 28(5):. PubMed ID: 37711069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neonatal Fc receptor stimulation induces ubiquitin c-terminal hydrolase-1 overexpression in podocytes through activation of p38 mitogen-activated protein kinase.
    Gan H; Feng S; Wu H; Sun Y; Hu R; Zhao Z; Zhang Z
    Hum Pathol; 2012 Sep; 43(9):1482-90. PubMed ID: 22406365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.